Conduit Pharmaceuticals Inc. (CDT) — Financial Flexibility Index
Conduit Pharmaceuticals Inc. (CDT) has a Financial Flexibility Index of 0.04x as of June 2026. Free cash flow of $83.40 Million (operating CF $42.74 Million minus capex $40.66 Million) represents 0% of total liabilities ($2.12 Billion). Check Conduit Pharmaceuticals Inc. (CDT) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Conduit Pharmaceuticals Inc. Financial Flexibility Index (2021–2025)
Historical Financial Flexibility Index trend for Conduit Pharmaceuticals Inc. across 5 annual periods. For the full cash flow conversion analysis, see Conduit Pharmaceuticals Inc. cash flow conversion.
Annual Financial Flexibility Index for Conduit Pharmaceuticals Inc. (2021–2025)
Year-by-year free cash flow to debt coverage for Conduit Pharmaceuticals Inc.. Explore debt repayment capacity of Conduit Pharmaceuticals Inc. to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.01x | $-13.15 Million | $-15.55 Million | $2.28 Billion | ▲ +99.3% |
| 2024 | -0.88x | $-9.63 Million | $-9.68 Million | $10.99 Million | ▲ +12.8% |
| 2023 | -1.01x | $-7.72 Million | $-7.72 Million | $7.68 Million | ▼ -348.0% |
| 2022 | -0.22x | $-2.27 Million | $-2.27 Million | $10.09 Million | ▲ +98.0% |
| 2021 | -11.17x | $-2.15 Million | $-2.15 Million | $192.51K | — |